期刊文献+

心脑器官的保护基础是血压充分的达标 被引量:8

Blood Pressure Targeting-the Basis of Cardiocerebral Protection
下载PDF
导出
摘要 降压达标对器官保护具有重要作用,合理、有效地进行血压的控制应作为心、脑、肾、血管疾病治疗的基础。大型临床试验结果提示,不同降压药物对器官的保护作用不同,高血压患者积极降低血压,可降低心脑血管事件。 Blood pressure targeting plays an important role in the organic protection, and well-controlled blood pressure should be the basis of heart, brain, kidney and vessel diseases'treatment. The results of some large-scale clinical trials bad indicated that different blood pressure-lowering drugs had different organic protection, and cardiocerebral events could decrease after blood pressures lowered effectively in hypertensive patients.
作者 孙宁玲
出处 《心血管病学进展》 CAS 2006年第5期543-545,共3页 Advances in Cardiovascular Diseases
关键词 血压 达标 器官保护 blood pressure targeting organic protection
  • 相关文献

参考文献10

  • 1中华人民共和国卫生部.中国居民营养与健康现状.2004.
  • 2Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:Principal results of the Hypertension Optimal Treatment (HOT) randomised trial.HOT Study Group[J].Lancet,1998,351(9118):1755-1762.
  • 3White WB.Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate[J].Blood Press Monit,2001,6:63-72.
  • 4Brown MJ,Palmer CR,Castaigne A,et al.Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium channel blocker or diuretic in the International Nifedipine GITS study:intervention as a Goal in hypertension treatment (INSIGHT)[J].Lancet,2000,356:366-372.
  • 5Agabiti RE,Trimarco B,Muiesan ML,et al.Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis(ELSA)[J].J Hypertens,2005,23:1091-1098.
  • 6Pitt B,Byington RP,Furberg CD,et al.Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial[J].Circulation,2000,102:1503-1510.
  • 7Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study(LIFE):A randomized trial against atenolol[J].Lancet,2002,359:995-1003.
  • 8Nissen S,Tuzcu EM,Libby P,et al.Effect of antihypertensive agents on cardiovascular events in patients with coronary heart disease and normal blood pressure.The CAMELOT Study:A randomized controlled trial[J].JAMA,2004,292:2217-2226.
  • 9Liu L,Zhang Y,Liu G,et al.The Felodipine Event Reduction (FEVER) Study:A randomized long-term placebo-controlled trial in Chinese hypertensive patients[J].J Hypertens,2005,23(12):2157-2172.
  • 10]Coleman MM,Kendall MF.The Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm[J].J Clin Pharmacy Therapeu,2005,31(4):299-307.

共引文献6

同被引文献30

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部